Cathie Wood Care Dx, Inc. Transaction History

Ark Investment Management LLC

$14.2 Billion
Q3 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 2,170,625 shares of CDNA stock, worth $34.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,170,625

Previous 2,100,157 3.36%

Holding current value

$34.6 Million

Previous $41 Million 23.09%

% of portfolio

0.22%

Previous 0.34%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$11.57 - $20.63 $815,314 - $1.45 Million	70,468 Added 3.36%	2,170,625 $31.6 Million
Q2 2025 Jul 30, 2025	SELL	$14.18 - $20.08 $3.51 Million - $4.96 Million	-247,225 Reduced 10.53%	2,100,157 $41 Million
Q1 2025 May 07, 2025	SELL	$17.64 - $25.07 $1.09 Million - $1.55 Million	-61,718 Reduced 2.56%	2,347,382 $41.7 Million
Q4 2024 Feb 04, 2025	SELL	$20.4 - $32.2 $11.8 Million - $18.7 Million	-579,497 Reduced 19.39%	2,409,100 $51.6 Million
Q3 2024 Oct 31, 2024	SELL	$14.41 - $33.99 $39.1 Million - $92.2 Million	-2,713,754 Reduced 47.59%	2,988,597 $93.3 Million

Q2 2024 Jul 26, 2024	SELL	$7.56 - $16.15 $1.22 Million - $2.61 Million	-161,695 Reduced 2.76%	5,702,351 $88.6 Million
Q1 2024 Apr 18, 2024	SELL	$7.96 - $12.37 $10.6 Million - $16.5 Million	-1,330,676 Reduced 18.5%	5,864,046 $62.1 Million
Q4 2023 Jan 17, 2024	BUY	$4.9 - $12.86 $2.53 Million - $6.63 Million	515,399 Added 7.72%	7,194,722 $86.3 Million
Q3 2023 Oct 18, 2023	BUY	$7.0 - $11.26 $286,811 - $461,355	40,973 Added 0.62%	6,679,323 $46.8 Million
Q2 2023 Jul 10, 2023	SELL	$7.61 - $9.46 $1.23 Million - $1.52 Million	-161,089 Reduced 2.37%	6,638,350 $56.4 Million
Q1 2023 Apr 17, 2023	BUY	$8.83 - $17.61 $5.4 Million - $10.8 Million	611,257 Added 9.88%	6,799,439 $62.1 Million
Q4 2022 Jan 24, 2023	BUY	$10.88 - $20.05 $4.36 Million - $8.04 Million	401,062 Added 6.93%	6,188,182 $0
Q3 2022 Oct 17, 2022	BUY	$16.06 - $26.39 $28.8 Million - $47.3 Million	1,791,670 Added 44.84%	5,787,120 $98.5 Million
Q2 2022 Jul 11, 2022	BUY	$20.49 - $39.72 $9.92 Million - $19.2 Million	484,216 Added 13.79%	3,995,450 $100 Million
Q1 2022 Apr 19, 2022	SELL	$28.19 - $46.6 $3.6 Million - $5.94 Million	-127,540 Reduced 3.51%	3,511,234 $130 Million
Q4 2021 Jan 28, 2022	BUY	$41.2 - $73.6 $9.42 Million - $16.8 Million	228,621 Added 6.7%	3,638,774 $165 Million
Q3 2021 Nov 12, 2021	SELL	$59.15 - $91.99 $68.3 Million - $106 Million	-1,153,957 Reduced 25.28%	3,410,153 $216 Million
Q2 2021 Aug 05, 2021	BUY	$63.02 - $95.11 $6.51 Million - $9.82 Million	103,286 Added 2.32%	4,564,110 $418 Million
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $23 Million - $38.1 Million	398,502 Added 9.81%	4,460,824 $304 Million
Q4 2020 Feb 12, 2021	BUY	$41.43 - $77.09 $91.3 Million - $170 Million	2,203,095 Added 118.5%	4,062,322 $294 Million
Q3 2020 Oct 30, 2020	BUY	$30.88 - $37.94 $18 Million - $22.1 Million	583,725 Added 45.76%	1,859,227 $70.5 Million
Q2 2020 Aug 11, 2020	BUY	$18.95 - $35.43 $9.24 Million - $17.3 Million	487,358 Added 61.84%	1,275,502 $45.2 Million
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $3.1 Million - $6.29 Million	222,706 Added 39.39%	788,144 $17.2 Million
Q4 2019 Jan 31, 2020	BUY	$19.24 - $28.41 $4.77 Million - $7.05 Million	248,138 Added 78.2%	565,438 $12.2 Million
Q3 2019 Nov 12, 2019	BUY	$20.03 - $40.08 $3.8 Million - $7.6 Million	189,692 Added 148.65%	317,300 $7.17 Million
Q2 2019 Jul 30, 2019	BUY	$25.78 - $39.77 $3.29 Million - $5.07 Million	127,608 New	127,608 $4.59 Million

Others Institutions Holding CDNA

# of Institutions

201

Shares Held

54.5M

Call Options Held

150K

Put Options Held

57.6K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $852M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account